Theranos Serves as a Cautionary Tale for Biotech Funding Post author:Sam Post published:March 15, 2018 Post category:BioPharma There are dangers in biotech funding and Theranos should serve as a warning. Source: BioSpace You Might Also Like SoCal's Vical Terminates 54% of Workforce to Focus Resources on Two Clinical Programs January 30, 2018 The Biggest Winners and Losers of JPM 2018 January 16, 2018 Is There A Silver Lining For Fitbit? February 14, 2017
SoCal's Vical Terminates 54% of Workforce to Focus Resources on Two Clinical Programs January 30, 2018
